Statewide HPV vaccine initiation among adolescent females in North Carolina

Sexually Transmitted Diseases

Volumn 37, Issue 9, 2010, Pages 549-556

  Reiter, Paul L ^a,b   Cates, Joan R ^b   McRee, Annie Laurie ^a   Gottlieb, Sami L ^c   Shafer, Autumn ^b   Smith, Jennifer S ^a,b   Brewer, Noel T ^a,b  

^a IL   (Australia)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CHILD; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DAUGHTER; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MASS IMMUNIZATION; MEDICAL EXAMINATION; MENINGOCOCCOSIS; NORMAL HUMAN; PARENT; RACE DIFFERENCE; SELF REPORT; UNITED STATES; URBAN AREA;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; INTENTION; NORTH CAROLINA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 77955925796     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181d73bf8     Document Type: Article

References (36)

1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-819.
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
3. Winer RL, Lee SK, Hughes JP, et al. Genital human papilloma-virus infection: Incidence and risk factors in a cohort of female University students. Am J Epidemiol 2003; 157:218-226.
4. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132:277-284.
5. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-1423.
6. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervi-covaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
7. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer\burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
8. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 2007; 121:621-632.
9. American Cancer Society. Cancer Facts and Figures, 2009. Atlanta, GA: American Cancer Society, 2009.
10. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995; 33:2058-2063.
11. Dinh TH, Sternberg M, Dunne EF, et al. Genital warts among 18-to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis 2008; 35:357-360.
12. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2):1-24.
13. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years\United States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:997-1001.
14. Christian WJ, Christian A, Hopenhayn C. Acceptance of the HPV vaccine for adolescent girls: Analysis of state-added questions from the BRFSS. J Adolesc Health 2009; 44:437-445.
15. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health 2007; 40:108-115
16. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
17. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2008 Summary Data Quality Report. Available at: ftp://ftp.cdc.gov/pub/Data/Brfss/2008-Summary- Data-Quality-Report.pdf.
18. U.S. Census Bureau. Metropolitan and micropolitan statistical areas. Available at: http://www.census.gov/population/www/metroareas/metroarea.html.
19. U.S. Census Bureau. American FactFinder, Census 2000. Available at: http://www.census.gov/.
20. North Carolina State Center for Health Statistics. North Carolina health statistics pocket guide 2007. Available at: http://www. schs.state.nc.us/SCHS/ data/pocketguide/2007/index.html.
21. Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillo-mavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 2009; 45:430-437.
22. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008; 113(suppl 10): 2855-2864.
23. Benard VB, Coughlin SS, Thompson T, et al. Cervical cancer incidence in the United States by area of residence, 1998 2001. Obstet Gynecol 2007; 110:681-686.
24. Shefer A, Markowitz L, Deeks S, et al. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 2008; 26(suppl 10):K68-K75.
25. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ 2008; 336:1056-1058.
26. Hildesheim A, Herrero R. Human papillomavirus vaccine should be given before sexual debut for maximum benefit. J Infect Dis 2007; 196:1431-1432.
27. Chao C, Slezak JM, Coleman KJ, et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009; 99:1137-1142.
28. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007; 45:107-114.
29. Kahn JA, Ding L, Huang B, et al. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: A national study of nurses. Pediatrics 2009; 123:1439-1445.
30. Markowitz LE, Sternberg M, Dunne EF, et al. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009; 200:1059-1067.
31. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance\United States, 2005. MMWR Surveill Summ 2006; 55:1-108.
32. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008; 359:821-832.
33. Arcury TA, Gesler WM, Preisser JS, et al. The effects of geography and spatial behavior on health care utilization among the residents of a rural region. Health Serv Res 2005; 40:135-155.
34. Katz ML, Wewers ME, Single N, et al. Key informants' perspectives prior to beginning a cervical cancer study in Ohio Appala-chia. Qual Health Res 2007; 17:131-141.
35. Reiter PL, Brewer NT, Gottlieb SL, et al. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009; 69:475-480.
36. Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of HPV vaccine uptake. Paper presented by: Presented at the American Public Health Association Annual Meeting; November, 2009, Philadelphia, PA.